RECRUITING

Esophageal Cancer Multimodal Prehabilitation Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this research study is to investigate the feasibility of implementing a prehabilitation program that aims to improve a patient's physical, nutritional, and sleep health before surgery in an older, at-risk group with esophageal cancer.

Official Title

A Multimodal Prehabilitation Feasibility Study for Older Adult Patients at High Risk for Poor Postoperative Outcomes Prior to Esophageal Cancer Surgery

Quick Facts

Study Start:2023-12-01
Study Completion:2026-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06027515

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 65 years of age and over
  2. * Adult male or non-pregnant female volunteers
  3. * Completed neoadjuvant chemotherapy or radiotherapy for esophageal cancer
  4. * At least four weeks to esophageal cancer surgery
  5. * Without skin conditions that preclude wearing sensors
  6. * Able to speak English and consent
  1. * Participants in any other interventional study that may bias results or limit study adherence during our study
  2. * Dietary restrictions that prevent consumption of nutritional supplements
  3. * Women who are pregnant, nursing, or at risk of becoming pregnant
  4. * Profound physical disability (for example, quadriplegia) that precludes participation in any aerobic or strength training.

Contacts and Locations

Study Contact

Hassan Dashti, PhD
CONTACT
6177269132
Hassan.dashti@mgh.harvard.edu
Federico Ciardi, MBBS
CONTACT
646-574-7682
fciardi@mgh.harvard.edu

Principal Investigator

Hassan Dashti, PhD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02215
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Hassan Dashti, PhD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-01
Study Completion Date2026-01-31

Study Record Updates

Study Start Date2023-12-01
Study Completion Date2026-01-31

Terms related to this study

Keywords Provided by Researchers

  • Esophageal Cancer
  • Esophageal Neoplasms

Additional Relevant MeSH Terms

  • Esophageal Cancer
  • Esophageal Neoplasms